NRAS and Thyroid adenoma: Transgenic mice with human NRAS oncogene expression in the thyrocytes under the control of Tg promoter (Tg-NRAS) developed thyroid adenomas (11%) and invasive follicular carcinomas (40%), with approximately 25% showing poor differentiation, lymphovascular invasion and increased metastatic risk [28,30].